SEC Form 4 · accession 0001179110-16-032857
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig Barrows
Officer — Vice-President,General Counsel
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 10:59 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.84 | Dec 9, 2016 | A | 55,000 | A | Dec 9, 2017 | Dec 9, 2026 | Common stock | 55,000 | 55,000 | D |
Explanation of responses
- F1Exercisable as to 18,334 shares commencing on December 9, 2017, 18,333 shares commencing on December 9, 2018 and 18,333 shares commencing on December 9, 2019.